CervoMed Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
CervoMed Inc. (CRVO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 2.22 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-07
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 51.54K shares, a 74594.20% increase year-over-year.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 0.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-06-30 was 16.67K shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-03-31 was 154.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 68.37K shares, a 190.08% increase from fiscal 2024.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 23.57K shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 610.00 shares, a 92.90% decline from fiscal 2021.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 8.59K shares, a 4896.51% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2.22K shares 10-Q · filed 2026-08-07 | |||||
| 2025-12-31 | 51.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 51.54K shares derived: sum of 2 quarters · filed 2026-03-13 | 68.21K shares derived: sum of 3 quarters · filed 2026-03-13 | 68.37K shares 10-K · filed 2026-03-13 | ||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 16.67K shares derived: sum of 2 quarters · filed 2025-11-07 | 16.83K shares 10-Q · filed 2025-11-07 | 16.90K shares derived: sum of 4 quarters · filed 2025-11-07 | ||
| 2025-06-30 | 16.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 16.83K shares 10-Q · filed 2025-08-08 | 16.90K shares derived: sum of 3 quarters · filed 2025-08-08 | |||
| 2025-03-31 | 154.00 shares 10-Q · filed 2025-05-12 | 223.00 shares derived: sum of 2 quarters · filed 2025-05-12 | ||||
| 2024-12-31 | 69.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 23.57K shares 10-K · filed 2025-03-17 | ||||
| 2024-09-30 | 23.50K shares 10-Q · filed 2024-11-12 | |||||
| 2022-12-31 | 171.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 350.00 shares derived: sum of 2 quarters · filed 2023-03-24 | 610.00 shares 10-K · filed 2023-03-24 | |||
| 2022-09-30 | 179.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 439.00 shares 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | 260.00 shares 10-Q · filed 2022-08-12 | |||||
| 2021-12-31 | 8.59K shares 10-K · filed 2023-03-24 | |||||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | 25.00 shares derived: sum of 2 quarters · filed 2022-03-18 | 25.00 shares derived: sum of 3 quarters · filed 2022-03-18 | 172.00 shares 10-K · filed 2022-03-18 | ||
| 2020-09-30 | 25.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 25.00 shares derived: sum of 2 quarters · filed 2020-11-12 | 172.00 shares 10-Q · filed 2020-11-12 | 172.00 shares derived: sum of 4 quarters · filed 2021-03-17 | ||
| 2020-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 147.00 shares 10-Q · filed 2020-08-07 | 147.00 shares derived: sum of 3 quarters · filed 2021-03-17 | 147.00 shares derived: sum of 4 quarters · filed 2021-03-17 | ||
| 2020-03-31 | 147.00 shares 10-Q · filed 2020-05-11 | 147.00 shares derived: sum of 2 quarters · filed 2021-03-17 | 147.00 shares derived: sum of 3 quarters · filed 2021-03-17 | 147.00 shares derived: sum of 4 quarters · filed 2021-03-17 | ||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-17 | 0.00 shares derived: sum of 3 quarters · filed 2021-03-17 | 147.00 shares 10-K · filed 2021-03-17 | ||
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-08 | 147.00 shares 10-Q · filed 2019-11-08 | -1.90K shares derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 147.00 shares 10-Q · filed 2019-08-08 | -1.90K shares derived: sum of 3 quarters · filed 2020-03-17 | -1.90K shares derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2019-03-31 | 147.00 shares 10-Q · filed 2019-05-09 | -1.90K shares derived: sum of 2 quarters · filed 2020-03-17 | -1.90K shares derived: sum of 3 quarters · filed 2020-03-17 | -1.90K shares derived: sum of 4 quarters · filed 2020-03-17 | ||
| 2018-12-31 | -2.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -2.04K shares derived: sum of 2 quarters · filed 2020-03-17 | -2.04K shares derived: sum of 3 quarters · filed 2020-03-17 | 147.00 shares 10-K · filed 2020-03-17 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-13 | 2.19K shares 10-Q · filed 2018-11-13 | 829.00 shares derived: sum of 4 quarters · filed 2019-03-19 | ||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 2.19K shares 10-Q · filed 2018-08-10 | 829.00 shares derived: sum of 3 quarters · filed 2019-03-19 | 829.00 shares derived: sum of 4 quarters · filed 2019-03-19 | ||
| 2018-03-31 | 2.19K shares 10-Q · filed 2018-05-10 | 829.00 shares derived: sum of 2 quarters · filed 2019-03-19 | 829.00 shares derived: sum of 3 quarters · filed 2019-03-19 | 829.00 shares derived: sum of 4 quarters · filed 2019-03-19 | ||
| 2017-12-31 | -1.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | -1.36K shares derived: sum of 2 quarters · filed 2019-03-19 | -1.36K shares derived: sum of 3 quarters · filed 2019-03-19 | 98.00 shares 10-K · filed 2019-03-19 | 1.46K shares 10-K · filed 2018-04-02 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-13 | 1.46K shares 10-Q · filed 2017-11-13 | |||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 1.46K shares 10-Q · filed 2017-08-14 | ||||
| 2017-03-31 | 1.46K shares 10-Q · filed 2017-05-15 | |||||
| 2012-12-31 | 0.00 shares derived: 10-Q/A 12 month − 10-Q 9 month · filed 2013-05-20 | 100.00K shares derived: sum of 2 quarters · filed 2013-05-20 | -7.28M shares 10-Q/A · filed 2013-05-20 | |||
| 2012-09-30 | 100.00K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | -7.28M shares 10-Q · filed 2012-11-19 | ||||
| 2012-06-30 | -7.38M shares 10-Q/A · filed 2012-09-07 | |||||
| 2011-12-31 | -3.11M shares 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |